| 000 | 00877 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518075947.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a1792-1074 | ||
| 024 | 7 |
_a10.3892/ol.2019.11166 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Lichao | |
| 245 | 0 | 0 |
_aLINC00365-SCGB2A1 axis inhibits the viability of breast cancer through targeting NF-κB signaling. _h[electronic resource] |
| 260 |
_bOncology letters _cJan 2020 |
||
| 300 |
_a753-762 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aYan, Xiaoyu | |
| 700 | 1 | _aYu, Sihang | |
| 700 | 1 | _aZhong, Xinru | |
| 700 | 1 | _aTian, Rui | |
| 700 | 1 | _aXu, Long | |
| 700 | 1 | _aBian, Xuehai | |
| 700 | 1 | _aSu, Jing | |
| 773 | 0 |
_tOncology letters _gvol. 19 _gno. 1 _gp. 753-762 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/ol.2019.11166 _zAvailable from publisher's website |
| 999 |
_c30479175 _d30479175 |
||